These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29344151)

  • 1. Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells.
    Gu Y; Zhang J; Guan H
    Oncol Lett; 2017 Dec; 14(6):7191-7196. PubMed ID: 29344151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma.
    Wang J; Ai Z; Chen J; Teng Y; Zhu J
    Oncol Lett; 2018 Jun; 15(6):9429-9435. PubMed ID: 29805666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EZH2 gene silenced by siRNA suppresses the growth and invasion of endometrial carcinoma cells].
    Leng L; Huang Q; Dong Y; Yu H; Tian Y; Peng G
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):866-9. PubMed ID: 23803199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma.
    Jia N; Li Q; Tao X; Wang J; Hua K; Feng W
    Oncol Lett; 2014 Nov; 8(5):2049-2054. PubMed ID: 25295088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2.
    Zhang C; Shao S; Zhang Y; Wang L; Liu J; Fang F; Li P; Wang B
    Life Sci; 2020 Feb; 243():117295. PubMed ID: 31927050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
    Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
    Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix.
    Priya A; Chaurasia JK; K P; Panwar H; Yadav SK; Kapoor N
    Cureus; 2023 Mar; 15(3):e36946. PubMed ID: 37131568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
    Guo ZL; Chen K; Wang XQ; Hu W
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms].
    LIANG BJ; LI XP; LU J; LIN SX; LIU X; LI G; ZHANG B; WANG L; LUO HN; WAN RQ; TIAN WD
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):298-304. PubMed ID: 22800347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
    Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
    Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
    Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
    Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
    Wang HR; Wang MH; Lian GY; Wu DG
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
    Wang H; Wang M; Lian G; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
    Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
    Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.
    Zhang G; Wu YJ; Yan F
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TRA2B in endometrial carcinoma and its regulatory roles in endometrial carcinoma cells.
    Paudel D; Ouyang Y; Huang Q; Zhou W; Wang J; Poorekhorsandi ME; Dhakal B; Tong X
    Oncol Lett; 2019 Sep; 18(3):2455-2463. PubMed ID: 31452736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.